Cenci M, Chieppa A, Vecchione A
Dipartimento di Medicina Sperimentale e Patologia, Cattedra di Citopatologia, Università degli Studi di Roma, Rome, Italy.
Minerva Ginecol. 2001 Feb;53(1):57-62.
AGUS (Atypical Glandular Cells of Undetermined Significance), or AGCUS, is a category for reporting doubtful or suspicious glandular changes of the uterine cervix. Glandular lesions are not well known by the cytopathologist and their cytologic criteria are not completely reproducible. Only with the introduction of The Bethesda System (TBS) in 1988, the presence of endocervical cells is considered essential to correctly evaluate a cervical specimen. The origin of atypical glandular cells, endometrial or endocervical, should be distinguished. Moreover, endocervical AGUS should be further qualified as favor reactive or favor neoplastic or Adeno-carcinoma in situ (AIS) . Recently, it has been proposed to classify endocervical AGUS in a) AIS; and b) AGUS that cannot rule out AIS when incomplete criteria of AIS are present. Moreover, the origin of AGUS is sometimes impossible to know. In these cases, the diagnosis is AGUS not otherwise specified (NOS). The clinical management of AGUS presents different options depending on its origin or its further qualification: cytologic follow-up, colposcopy and eventual biopsy, endocervical or endometrial curettage, hysteroscopy, human papillomavirus typing, etc. including conization and hysterectomy. In conclusion, an appropriate clinical management is needed to detect glandular or squamous lesions that can be frequently identified in the AGUS follow-up.
